The most common side effects of Ozempic are nausea, vomiting, diarrhea, abdominal pain, and constipation. All five occur in at least 5% of people taking the medication, and digestive symptoms overall affect roughly a third of users. The good news: most of these side effects are strongest during the first few weeks of treatment and tend to fade as your body adjusts.
Digestive Side Effects by the Numbers
FDA clinical trial data breaks down how often each symptom occurs at the two main treatment doses compared to a placebo:
- Nausea: 15.8% at the 0.5 mg dose, 20.3% at 1 mg (vs. 6.1% on placebo)
- Vomiting: 5.0% at 0.5 mg, 9.2% at 1 mg (vs. 2.3% on placebo)
- Diarrhea: 8.5% at 0.5 mg, 8.8% at 1 mg (vs. 1.9% on placebo)
- Abdominal pain: 7.3% at 0.5 mg, 5.7% at 1 mg (vs. 4.6% on placebo)
- Constipation: 5.0% at 0.5 mg, 3.1% at 1 mg (vs. 1.5% on placebo)
Nausea is the standout. About one in five people on the 1 mg dose experience it. The higher the dose, the more likely you are to have digestive trouble: gastrointestinal side effects hit 32.7% of people on the 0.5 mg dose and 36.4% on the 1 mg dose. For the newer 2 mg dose, that figure climbs to 34%, compared to 30.8% at 1 mg. Despite these numbers, only about 3% to 4% of patients in trials found the symptoms bad enough to stop taking the medication entirely.
Why Ozempic Causes Stomach Problems
Ozempic works by mimicking a hormone called GLP-1, which your gut naturally produces after eating. One of its key effects is slowing down how fast your stomach empties food into the small intestine. That delay is part of how the drug reduces appetite and helps control blood sugar, but it’s also why so many people feel nauseated, bloated, or overly full, especially early on.
The stomach-slowing effect is strongest during the first four weeks of treatment. Research shows that after about 16 weeks of continuous use, gastric emptying speeds back up somewhat, though it still doesn’t fully return to normal. This is why the prescribing schedule starts you at a low 0.25 mg dose for four weeks before stepping up. That starter dose isn’t meant to treat diabetes or promote weight loss. It exists specifically to let your body acclimate.
When Side Effects Peak and Fade
Most digestive side effects appear during the first few weeks of treatment or right after a dose increase. Nausea in particular tends to be mild to moderate and fades once you’re past the dose escalation phase. For many people, symptoms resolve within a few weeks at each new dose level.
The pattern repeats each time your dose goes up: a few days of stronger nausea or stomach discomfort, followed by a gradual return to normal. If you’re stepping from 0.5 mg to 1 mg, expect that transition to come with a brief flare of the same symptoms you experienced when starting. This doesn’t mean the side effects are getting worse long-term. It means your body needs a short adjustment period at each new level.
Practical Ways to Reduce Nausea
You can’t eliminate the side effects entirely, but dietary changes make a real difference. The core strategy is eating smaller meals more frequently throughout the day instead of two or three large ones. Eat slowly and stop when you feel satisfied rather than full. Because your stomach is emptying more slowly, large portions sit longer and make nausea worse.
Certain foods are easier to tolerate during the adjustment period:
- Plain, starchy foods: rice, noodles, potatoes, toast, crackers
- Gentle fruits: bananas, applesauce, plain apples
- Cold or chilled foods: plain yogurt, gelatin, popsicles
- Broth-based soups
Foods that tend to make nausea worse include anything greasy, fried, very spicy, overly sweet, or strong-smelling. Sipping water frequently throughout the day helps too, especially if vomiting or diarrhea is causing fluid loss. After eating, avoid intense exercise, but don’t lie down flat either. A gentle walk or simply sitting upright is the better option.
You may have seen claims online that injecting Ozempic in the upper arm instead of the abdomen reduces nausea. There’s no clinical evidence for this. Semaglutide enters the bloodstream and works the same way regardless of injection site.
Low Blood Sugar Risk
Ozempic on its own carries a low risk of hypoglycemia. The drug primarily works by boosting insulin production when blood sugar is already elevated, so it doesn’t typically drive blood sugar dangerously low on its own. The combination of Ozempic with metformin, one of the most common pairings, also maintains a low hypoglycemia risk.
The exception is if you’re also taking insulin or a sulfonylurea. These medications independently lower blood sugar, and adding Ozempic on top can push levels too low. If you’re on one of these combinations, your prescriber will likely reduce the dose of the other medication to compensate.
Muscle Loss During Weight Loss
This side effect gets less attention but matters, especially for long-term users. When you lose weight on Ozempic, not all of it comes from fat. Studies suggest that 25% to 39% of total weight lost over 36 to 72 weeks comes from lean mass, which includes muscle. By comparison, people who lose weight through diet alone typically lose 10% to 30% of their weight as lean mass, though they also tend to lose less total weight.
The practical takeaway: resistance exercise becomes more important when you’re on Ozempic. Maintaining muscle through strength training can offset some of this loss and helps preserve metabolic health, bone density, and physical function as the number on the scale drops.
Serious but Rare Side Effects
Most people experience only the digestive symptoms described above. But Ozempic does carry warnings for less common, more serious reactions.
Diabetic retinopathy complications occurred in 3% of patients taking Ozempic in clinical trials, compared to 1.8% on placebo. The risk was more pronounced in people who already had a history of diabetic eye disease: 8.2% in the Ozempic group versus 5.2% on placebo. Rapid improvements in blood sugar control can sometimes worsen existing eye damage in the short term, which is likely the mechanism here.
Pancreatitis, including severe forms, has been reported in postmarketing surveillance. Symptoms include persistent, severe abdominal pain that may radiate to the back, sometimes with vomiting. This is distinct from the mild stomach discomfort that’s common during dose escalation.
The FDA label also now lists intestinal obstruction, severe constipation including fecal impaction, and ileus (where the intestines temporarily stop moving food through) in its postmarketing experience section. Ozempic is not recommended for people with severe gastroparesis, a condition where the stomach already empties abnormally slowly. These serious gastrointestinal events are rare, but they reflect the same underlying mechanism, slowed gut motility, that causes the common side effects.